Cross-Reactive Polyclonal Antibodies to the Inner Core of Lipopolysaccharide from Neisseria meningitidis

AUTOR(ES)

Andersen, Svein Rune

FONTE

American Society for Microbiology

RESUMO

Sera from mice immunized with native or detergent-extracted outer membrane vesicles derived from lipopolysaccharide (LPS) mutant 44/76Mu-4 of Neisseria meningitidis were analyzed for antibodies to LPS. The carbohydrate portion of 44/76Mu-4 LPS consists of the complete inner core, Glcβ1→4[GlcNAc α1→2Hep α1→3]Hep α1→5KDO[4→2αKDO]. Immunoblot analysis revealed that some sera contained antibodies to wild-type LPS which has a fully extended carbohydrate chain of immunotype L3,7, as well as to the homologous LPS. Sera reacted only weakly to LPS from 44/76Mu-3, which lacks the terminal glucose of the inner core. No binding to more truncated LPS was observed. Consequently, the cross-reactive epitopes are expressed mainly by the complete inner core. Dephosphorylation of wild-type LPS abolished antibody binding to LPS in all but one serum. Thus, at least two specificities of cross-reactive antibodies exist: one is dependent on phosphoethanolamine groups in LPS, and one is not. Detection of these cross-reactive antibodies strongly supports the notion that epitopes expressed by meningococcal LPS inner core are also accessible to antibodies when the carbohydrate chain is fully extended. Also, these inner core epitopes are sufficiently immunogenic to induce antibody levels detectable in polyclonal antibody responses. Meningococci can escape being killed by antibodies to LPS that bind only to a specific LPS variant, by altering the carbohydrate chain length. Cross-reactive antibodies may prevent such escape. Therefore, inner core LPS structures may be important antigens in future vaccines against meningococcal disease.

Documentos Relacionados

• Infection with an Avirulent phoP Mutant of Neisseria meningitidis Confers Broad Cross-Reactive Immunity
• Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain.
• Cross-reactive monoclonal antibodies for diagnosis of pneumococcal meningitis.
• Enteric Bacteria Cross-Reactive with Neisseria meningitidis Groups A and C and Diplococcus pneumoniae Types I and III
• Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains.